Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network

IntroductionBerotralstat, the first oral plasma kallikrein inhibitor approved for hereditary angioedema (HAE) prophylaxis, may be associated with gastrointestinal (GI) side effects, particularly during the first three months of therapy. Probiotics have been shown to reduce GI disturbances in several...

全面介紹

書目詳細資料

Principais autores:	Antonio Gidaro, Maria Domenica Guarino, Francesco Arcoleo, Donatella Bignardi, Cristian D’Antonio, Luisa Brussino, Pietro Accardo, Stefania Nicola, Stefano Pucci, Miriam Cognigni, Valentina Popescu Janu, Chiara Cogliati, Emanuele Bizzi, Mauro Cancian
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2026-04-01
叢編:	Frontiers in Immunology
主題:	berotralstat gastrointestinal side effects hereditary angioedema ITACA long term prophylaxis microbiome
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1790199/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!